Filtrer vos résultats
- 4
- 4
- 4
- 1
- 1
- 2
- 4
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
Reduction of extended-release tacrolimus dose in low immunological risk kidney transplant recipients increases risk of rejection and appearance of DSA - a randomized studyAmerican Journal of Transplantation, 2016
Article dans une revue
hal-01400266v1
|
|||
|
Eight-Year Results of the Spiesser Study, a Randomized Trial Comparing de Novo Sirolimus and Cyclosporine in Renal TransplantationTransplant International, 2016, 29 (1), pp.41-50. ⟨10.1111/tri.12656⟩
Article dans une revue
hal-03157732v1
|
||
Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French CohortTransplantation, 2018, 102 (5), pp.860-867. ⟨10.1097/TP.0000000000002009⟩
Article dans une revue
hal-03573109v1
|
|||
|
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patientsKidney International, 2020, 98 (6), pp.1519-1529. ⟨10.1016/j.kint.2020.07.042⟩
Article dans une revue
hal-03340159v1
|